Home / Duloxetine / Czechia
CZ ATC N06AX21 · updated 2 Nov 2026
Duloxetine shortage in Czechia
Is there a Duloxetine shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Duloxetine products are reported short in Czechia, the first since 28 Jul 2025. The company estimate for the return is 5 Jan 2027 (latest 15 Mar 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, France, Italy, Spain, Ireland, Austria, Belgium, Sweden, Japan, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | DOLYXAN 60MG 60MG CPS ETD 28 | BELUPO lijekovi i kozmetika, d.d., Koprivnica | 28 Jul 2025 | 5 Jan 2027 | Other Stažení šarže léčivého přípravku. |
| CZ | DOLYXAN 30MG 30MG CPS ETD 28 | BELUPO lijekovi i kozmetika, d.d., Koprivnica | 17 Mar 2026 | 5 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | DULOXETIN +PHARMA 60MG 60MG CPS ETD 28 anticipated | +pharma arzneimittel gmbh, Graz | 2 Dec 2026 | 15 Mar 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.